会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • IMMUNOSUPPRESSIVE AGENTS
    • 免疫抑制剂
    • WO1996030381A1
    • 1996-10-03
    • PCT/DK1996000124
    • 1996-03-27
    • NOVO NORDISK A/SRASMUSSEN, Frank, WintherSTRANGE, PoulBREINHOLT, Jens
    • NOVO NORDISK A/S
    • C07G259/04
    • C07C271/22A61K31/42C07C259/06
    • Amino amide derivatives of general formula (I), wherein R is hydrogen or C1-3-alkyl, optionally substituted with hydroxy, R is hydrogen, straight or branched C1-6-alkyl, or straight or branched C1-6-alkyl, mono-, di- or trisubstituted in any position with hydroxy, or R and R forms a C4-6-cycloalkyl-group, optionally mono-, di-, or trisubstituted in any position with hydroxy, R is hydrogen, methyl, ethyl, vinyl, iso-propyl, allyl, -R -(C=O)-R or -R -(CR R )-R , wherein R is methano or ethano, R is C1-20-alkyl, optionally substituted in any position with oxo, hydroxy, methyl or ethyl, R and R are hydrogen or hydroxy, R is hydrogen or hydroxy, R is methyl, ethyl, vinyl, iso-propyl, allyl, -R -(C=O)-R or -R -(CR R )-R , wherein R is methano or ethano, R is C1-20-alkyl, optionally substituted in any position with oxo, hydroxy, methyl or ethyl, R and R are hydrogen or hydroxy, or pharmaceutically acceptable salts thereof are useful for treating ailments related to the immune system.
    • 通式(I)的氨基酰胺衍生物,其中R 1为氢或任选被羟基取代的C 1-3 - 烷基,R 2为氢,直链或支链C 1-6 - 烷基或直链或支链C1 -6-烷基,在羟基的任何位置单取代,二取代或三取代,或R 1和R 2形成C 4-6 - 环烷基,任选地在任何位置单,二或三取代 具有羟基,R 3是氢,甲基,乙基,乙烯基,异丙基,烯丙基,-R 8 - (C = O)-R 4或-R 8 - (CR 5) R 6)-R 4,其中R 8是甲基或乙亚烷基,R 4是任选被氧代,羟基,甲基或乙基取代的C 1-20 - 烷基,R 5, 和R 6是氢或羟基,R 7是氢或羟基,R 9是甲基,乙基,乙烯基,异丙基,烯丙基,-R 13 - (C = O) R 10或-R 13 - (CR 11 R 12)-R 10,其中R 13是甲醇或乙醇,R 10是C 1-20烷基,任选地被任意取代 羟基,甲基或乙基的取代基,R 11和R 12是氢或羟基或其药学上可接受的盐 其用于治疗与免疫系统相关的疾病。
    • 6. 发明申请
    • FUNGICIDALLY ACTIVE COMPOUNDS
    • 杀真菌活性化合物
    • WO1992005191A1
    • 1992-04-02
    • PCT/DK1991000273
    • 1991-09-17
    • NOVO NORDISK A/SNIELSEN, Ruby, IoneBREINHOLT, JensJENSEN, Georg, Wilhelm
    • NOVO NORDISK A/S
    • C07K11/02
    • A01N63/04C07K7/06C07K11/02
    • Novel compounds of the general composition I, Lactate (1), Glycine (1), Valine (4), Isoleucine (1), pipecolic acid (1), Aspartic acid (1), Tyrosine (1), wherein each amino acid residue independently may occur in L- or D- form, and wherein the number in parenthesis indicates the number of occurrences of each moiety, and derivatives thereof are disclosed. The compounds are producible by aerobic cultivation on suitable nutrient media under suitable conditions of a strain of the fungus Curvularia sp., subsequent recovery of the active component from the fermentation medium, and optionally modifying the active compound to obtain a compound of the desired general composition. Disclosed are also microorganisms capable of producing said compounds, compositions containing said compounds, and the use of such compositions for controlling fungi in crops, and in the preservation of wood, paints, cosmetics, and edible products.
    • 一般组合物I,乳酸(1),甘氨酸(1),缬氨酸(4),异亮氨酸(1),哌可酸(1),天冬氨酸(1),酪氨酸(1))的新型化合物,其中每个氨基酸残基 独立地可以以L-或D-形式存在,并且其中括号中的数字表示每个部分的出现次数,并且其衍生物被公开。 这些化合物可以通过在合适的营养培养基上在真菌曲霉属菌株的合适条件下进行需氧培养来生产,随后从发酵培养基中回收活性成分,以及任选地改性活性化合物以获得所需的一般组成的化合物 。 还公开了能够产生所述化合物的微生物,含有所述化合物的组合物,以及这些组合物用于控制作物中的真菌以及保护木材,油漆,化妆品和可食用产品的用途。
    • 10. 发明申请
    • ACTIVE BIO-COMPOUNDS
    • 活性生物化合物
    • WO1997023486A1
    • 1997-07-03
    • PCT/DK1996000543
    • 1996-12-18
    • NOVO NORDISK A/SDEMUTH, HelleBREINHOLT, JensNIELSEN, Salka, E.GÜRTLER, Hanne
    • NOVO NORDISK A/S
    • C07D498/04
    • C07D498/04A01N43/90A23L3/3544A23L3/3571C09D5/14C12P17/188
    • The invention relates to biologically active novel compounds having general formula (I), wherein R , R , R , and R independently are hydrogen, straight or branched chain alkyl with 1-6 carbon atoms, straight or branched chain alkenyl with 2-6 carbon atoms, straight or branched chain alkynyl with 2-6 carbon atoms, or R and R independently are acyl (-COR), where R is defined as R to R above, and R and R are as above, X is halogen, preferably Cl or Br, especially Cl, mono- or plurisubstituted in the ring. Also disclosed are methods of preparing said compounds, fungicidal compositions comprising, as an active ingredient, these compounds, use of the compounds, and methods of controlling fungi at loci infested or liable to be infested therewith.
    • 本发明涉及具有通式(I)的生物活性新型化合物,其中R 1,R 2,R 3和R 4独立地是氢,具有1-6个碳原子的直链或支链烷基 原子,具有2-6个碳原子的直链或支链烯基,具有2-6个碳原子的直链或支链炔基,或者R 1和R 3独立地是酰基(-COR),其中R定义为R R 4和R 4如上所述,X是卤素,优选Cl或Br,特别是C1,在环中被单取代或多取代。 还公开了制备所述化合物的方法,所述杀真菌组合物包含作为活性成分的这些化合物,所述化合物的用途,以及在侵染或易于侵染的基因座中控制真菌的方法。